Acyclovir-induced renal failure in an obese patient

American Journal of Health-System Pharmacy

Volumn 66, Issue 14, 2009, Pages 1288-1291

  Hernandez, Jovino Ocasio ^a   Norstrom, Jeni ^b   Wysock, Glenn ^a  

^a Winter Haven Hospital   (United States)

^b VA BOSTON HEALTHCARE SYSTEM   (United States)

Author keywords

Acyclovir; Antivirals; Doxycycline; Kidney failure; Moxifloxacin; Obesity; Toxicity

Indexed keywords

ACICLOVIR; CITRATE SODIUM; CREATININE; DOXYCYCLINE; GLUCOSE; MOXIFLOXACIN; UREA;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CEREBROSPINAL FLUID EXAMINATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; CREATININE BLOOD LEVEL; DRUG WITHDRAWAL; HEALTH STATUS; HERPES SIMPLEX ENCEPHALITIS; HUMAN; KIDNEY FAILURE; LUMBAR PUNCTURE; MALE; MENINGITIS; NEPHROTOXICITY; OBESITY; OXYGEN THERAPY; PRIORITY JOURNAL; SLEEP APNEA SYNDROME; UREA NITROGEN BLOOD LEVEL;

EID: 67650964050     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp080307     Document Type: Article

References (22)

1. Zovirax (acyclovir) package insert. Greenville, NC: GlaxoSmithKline; 2003.
2. Perazella MA. Drug-induced renal failure: update on new medications and unique mechanisms of nephrotoxicity. Am J Med Sci. 2003; 325:349-362
3. Perazella MA. Crystal-induced acute renal failure. Am J Med. 1999; 106:459-465
4. Selby PJ, Powless RL, Janeson B et al. Parenteral acyclovir therapy for herpes-virus infections in man. Lancet. 1979; 2:1267-1270 (Pubitemid 10172612)
5. Bridgen D, Rosling AE, Woods NC. Renal function after acyclovir intravenous injection. Am J Med. 1982; 73:182-185
6. Jones PG, Beier-Hanratty SA. Acyclovir: neurologic and renal toxicity. Ann Intern Med. 1986; 104:892. Letter.
7. Mihara AI, Mori T, Nakazato T et al. Acute renal failure caused by intravenous acyclovir for disseminated varicella zoster virus infection. Scand J Infect Dis. 2007; 39:94-95 (Pubitemid 46277158)
8. Holloway WJ. Preliminary report on intravenous doxycycline. Del Med J. 1971; 43:394-397
9. Peterslund NA, Larsen ML, Mygind H. Acyclovir crystalluria. Scand J Infect Dis. 1988; 20:225-228
10. Sawyer MH, Webb DE, Balow JE et al. Acyclovir-induced renal failure: clinical course and histology. Am J Med. 1988; 84:1067-1071 (Pubitemid 18150086)
11. Giustina A, Romanelli G, Cimino A et al. Low-dose acyclovir and acute renal failure. Ann Intern Med. 1988; 108:312. Letter.
12. Vomiero G, Carpenter B, Robb I et al. Combination of ceftriaxone and acyclovir - an underestimated nephrotoxic potential? Pediatr Nephrol. 2002; 17: 633-637
13. Bassioukas K, Katopodis K, Christophorou N et al. Acute renal failure induced by intravenous acyclovir. J Eur Acad Dermatol Venereol. 2006; 20:1151-1152 (Pubitemid 44425988)
14. Becker BN, Fall P, Hall C et al. Rapidly progressive renal failure due to acyclovir: case report and review of the literature. Am J Kidney Dis. 1993; 22:611-615 (Pubitemid 23308976)
15. Krieble BF, Rudy DW, Glick MR et al. Acyclovir neurotoxicity and nephrotoxicity - the role for hemodialysis. Am J Med Sci. 1993; 305:36-39
16. Wurtz R, Itokazu G, Rodvold K. Antimicrobial dosing in obese patients. Clin Infect Dis. 1997; 25:112-118 (Pubitemid 27293084)
17. Laskin OL. Clinical pharmacokinetics of acyclovir. Clin Pharmacokinet. 1983; 8:187-201.
18. Davis RL, Quenzer RW, Weller S et al. Acyclovir pharmacokinetics in morbid obesity. In: Programs and abstracts of the 31st Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology; 1991.
19. Micromedex Healthcare Series [Internet database]. Greenwood Village, CO: Thomson Healthcare. Updated periodically.
20. Britt LG. Use of doxycycline in surgical infections - report of 117 case studies with 13 different bacterial origins. J Tenn Med Assoc. 1969; 61:37-40.
21. Avelox (moxifloxacin) oral tablets and i.v. injection product information. West Haven, CT: Bayer HealthCare; 2007.
22. Naranjo CA, Busto U, Sellers EM et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981; 30:239-245